Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Delivers PEX010 to Bruyere Health Research Institute's Phase 3 Trial of Microdose Psilocybin in Palliative Care
Toronto, Ontario--(Newsfile Corp. - September 21, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX) (OTCQB: TRUFF) ("Rhelion" or the "Company") an Ontario-based organization adv
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-09-21 7:49 AM EDT | Rhelion Life Sciences Corp.
NuGen Announces Loan Agreement with Sol-Millennium Medical HK Limited
Toronto, Ontario--(Newsfile Corp. - September 21, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is pleased to announce the entering into of a loan agreement (the "Loan Agreement") dated September 18, 2026 with Sol-Millennium Medical HK Limited (the "Lender") in the amount of up to C$1.3 million (the "Loan"). The initial advance under the Loan Agreement will be provided to the Company in the amount of C$500,000 following confirma
Healthcare and Hospitals, Pharmaceuticals, Health
2026-09-21 7:42 AM EDT | NuGen Medical Devices Inc.
naia Relief Inc. Announces Launch of naia 24/7 Mind Mentor Through Strategic Partnership with Felix Global
Toronto, Ontario--(Newsfile Corp. - September 21, 2026) - naia Relief Inc. (TSXV: NAIA) ("naia Relief" or the "Company") is pleased to announce the launch of naia, its 24/7, 365-day mind mentor and well-being and performance platform, through a strategic partnership with Felix Global, a leading global talent and organizational solutions provider. The partnership represents an important milestone in naia Relief Inc.'s global commercialization strategy, providing organiza
2026-09-21 7:00 AM EDT | Naia Relief Inc.
QScreen AI Announces $681,000 Debt Settlement with Directors and Officers
Toronto, Ontario--(Newsfile Corp. - September 21, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP) ("QScreen", "QAI" or the "Company"), an innovator in physiological AI screening and developer of an intelligence platform for clinical and occupational health applications, is pleased to announce that it has agreed to settle an aggregate of $681,000 of indebtedness owing to certain directors and officers of the Company (the "Debt Settlement") through the issuance of approximately
2026-09-21 6:14 AM EDT | QScreen AI Inc.
Largest Real-World Study of the GI Genius(TM) Intelligent Endoscopy System Demonstrates Improved Adenoma Detection in Routine Clinical Practice
Dublin, Ireland--(Newsfile Corp. - September 21, 2026) - Cosmo N.V. (SIX: CMHC) (FSE: C43) ("Cosmo") today announced the results from its CADeNCE study. The study, led by Dominitz et al. and published in Gastroenterology, is the largest cluster-randomised quality improvement study of computer-aided detection (CADe) in colonoscopy. It analysed more than 334,000 procedures performed under routine clinical conditions by 816 endoscopists across 139 U.S. Veterans Health Ad
Healthcare and Hospitals, Health
2026-09-21 1:07 AM EDT | Cosmo Pharmaceuticals N.V.
TempraMed Reports Record July Sales and Strong August Performance, with Year-to-Date Sales Already Exceeding Full-Year 2025 Revenue
Toronto, Ontario--(Newsfile Corp. - September 18, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) (OTCQB: TMPTF) ("TempraMed" or the "Company"), a medical-technology innovator transforming how temperature-sensitive medications are stored and managed, is pleased to provide an interim sales update regarding its recent commercial performance. The Company reports that July 2026 sales reached approximately US$522,000, representing the highest monthly sales level in T
Technology, Biotechnology, Pharmaceuticals, Health
2026-09-18 4:45 PM EDT | TempraMed Technologies Ltd.
Unbuzzd Wellness Announces Resignation of Chief Executive Officer
Vancouver, British Columbia--(Newsfile Corp. - September 17, 2026) - Unbuzzd Wellness Inc. (the "Company" or "Unbuzzd"), the company behind unbuzzd™, the scientifically proven beverage formulated to accelerate alcohol metabolism, restore mental clarity and reduce hangover symptoms, announces that Richard Buzbuzian will resign from his position as Chief Executive Officer of the Company, effective October 1, 2026. The Company thanks Mr. Buzbuzian for his contributions and wishes him
2026-09-17 6:25 PM EDT | Unbuzzd Wellness Inc.
BetterLife Pharma Inc. Announces Closing of US$100 Million Public Offering of Common Shares and Pre-Funded Warrants
Vancouver, British Columbia--(Newsfile Corp. - September 17, 2026) - BetterLife Pharma Inc. (CSE: BETR) ("BetterLife" or the "Company"), a biotechnology company developing treatments for neurological disorders, is pleased to announce that it has closed its previously announced public offering (the "Offering") of common shares of the Company ("Common Shares") and pre-funded common share purchase warrants of the Company ("Pre-Funded Warrants" and, together wit
2026-09-17 10:41 AM EDT | BetterLife Pharma Inc.
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Supply and Licensing Agreement with the Centre for Human Drug Research for PEX010 in a Study of Low and Medium Dose Psilocybin
Toronto, Ontario--(Newsfile Corp. - September 17, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX0) (OTCQB: TRUFF) ("Rhelion" or the "Company") an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly ow
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-09-17 7:52 AM EDT | Rhelion Life Sciences Corp.
Altrova Health Announces Proposed Debt Settlement
Toronto, Ontario--(Newsfile Corp. - September 16, 2026) - Altrova Health Inc. (CSE: ROVA) (OTCQB: ATVHF) (FSE: WF8) ("Altrova Health" or the "Company") announces that it proposes to enter into debt settlement agreements with three consultants to settle aggregate indebtedness of C$215,000 through the issuance of an aggregate of 3,583,333 comm
2026-09-16 7:07 AM EDT | Altrova Health Inc.
Rise Nano Optics to Attend the Vision Council's 2026 Lab Leadership Forum
Vancouver, British Columbia--(Newsfile Corp. - September 16, 2026) - Rise Nano Optics Ltd. (CSE: EYE) (OTCQB: RNOLF) (FSE: U9Y) ("Rise" or the "Company"), a health technology company advancing vision care through patented nanotechnology lens solutions, today announced that the Company
2026-09-16 7:00 AM EDT | Rise Nano Optics Ltd.
CBD of Denver, Inc. (CBDD) Signs Definitive Share Exchange Agreement with BioCannabis M. IKE, Advancing Strategic Merger Toward Completion
Denver, Colorado--(Newsfile Corp. - September 15, 2026) - CBD of Denver, Inc. (OTCID: CBDD) ("CBDD" or the "Company") today announced that it has entered into a definitive Share Exchange Agreement with BioCannabis M. IKE ("BioCannabis"), a Greece-based company operating in the health and wellness sector. The agreement follows the Letter of Intent previously announced by the parties and the completion of CBDD's due diligence review. Following its review of BioCannabis' business, operatio
Cannabis, Health, Cannabis Extractor, Cannabis Manufacturer
2026-09-15 9:00 AM EDT | CBD of Denver Inc.
La Vie Health and Virotek Biosciences Partner to Advance the Next Generation of Precision Health
Ontario and Richmond Hill, Ontario--(Newsfile Corp. - September 15, 2026) - La Vie Health ("La Vie") and Virotek Biosciences ("Virotek") today announced a strategic collaboration to integrate advanced genomic insights into La Vie's broader physician-led preventative, precision and healthspan model. This partnership advances both companies' commitment to precision health, with Virotek adding a clinically contextualized genomic layer to La Vie's comprehensive precision-health prog
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-09-15 8:30 AM EDT | Virotek Biosciences Inc.
Adia Med Submits Fifth 2026 Clinical Study to IRB: Osteoarthritis Protocol for One-Time Systemic Treatment
Winter Park, Florida--(Newsfile Corp. - September 15, 2026) - Adia Med Inc. (OTCQB: ADIA), a regenerative medicine company, today announced that its subsidiary, Adia Med of Winter Park, LLC, has submitted a clinical study protocol to an Institutional Review Board for review and approval. The proposed study is designed to evaluate a one-time systemic treatment with AdiaVita, the Company's umbilical cord blood-derived stem cell and exosome product, in adults with osteoarthritis. Participa
Healthcare and Hospitals, Health
2026-09-15 8:00 AM EDT | Adia Med Inc.
Extendicare Announces September 2026 Dividend of C$0.0441 per Share
Markham, Ontario--(Newsfile Corp. - September 15, 2026) - Extendicare Inc. (TSX: EXE) ("Extendicare" or the "Company") announced that it has declared a cash dividend of C$0.0441 per common share of the Company for the month of September 2026, which is payable on October 15, 2026 to shareholders of record at the close of business on September 30, 2026. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada). About Extendicare
Healthcare and Hospitals, Pharmaceuticals, Health
2026-09-15 8:00 AM EDT | Extendicare Inc.
Rhelion Life Sciences Wholly Owned Subsidiary Filament Health Signs Supply and Licensing Agreement with the University of Southern California for PEX010 in a Trial for Psilocybin-Assisted Mindfulness Therapy
Toronto, Ontario--(Newsfile Corp. - September 15, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX0) (OTCQB: TRUFF) ("Rhelion" or the "Company"), an Ontario-based organization advancing innovation and research within the legal psychedelic sector, is pleased to announce that its wholly owned subsidiary, Filament Health Corp. ("Filament"), has entered into a supply and licensing agreement with the University of Southern California, on behalf of its Keck School of Medicine of USC, for t
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-09-15 7:59 AM EDT | Rhelion Life Sciences Corp.
naia Relief Inc. Announces Commencement of Trading on the TSX Venture Exchange Under the Symbol "NAIA" and Engages Independent Trading Group as Market Maker
Toronto, Ontario--(Newsfile Corp. - September 15, 2026) - naia Relief Inc. (TSXV: NAIA) ("naia Relief" or the "Company") is pleased to announce that its common shares have been approved for listing on the TSX Venture Exchange (the "TSXV") and will commence trading under the symbol "NAIA" effective September 15, 2026. The listing marks an important milestone in the Company's evolution and establishes naia Relief Inc. as a publicly traded company positioned to advance its growth st
2026-09-15 7:00 AM EDT | Naia Relief Inc.
BioHarvest Advances Botanical Synthesis Leadership as VINIA Daily Chews Unlock More Value from Its First Consumer Product
British Columbia and Rehovot, Israel--(Newsfile Corp. - September 15, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (TASE:
Biotechnology, Pharmaceuticals, Health
2026-09-15 7:00 AM EDT | BioHarvest Sciences Inc.
Holy Crap Foods to Exhibit at CHFA NOW Toronto, Debuting New Protein SKUs and Interactive AI Photo Experience
Vancouver, British Columbia--(Newsfile Corp. - September 15, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that its wholly owned subsidiary, Holy Crap Foods Inc. ("Holy Crap"), will be exhibiting at the CHFA NOW Toronto trade show on September 26 and 27, 2026, at Exhibition Place in Toronto, Ontario. CHFA NOW Toronto is one of Canada's premier trade events for the natural, organic, and wellne
2026-09-15 6:00 AM EDT | Restart Life Sciences Corp.
Edison Issues Report on Severfield (SFR)
London, United Kingdom--(Newsfile Corp. - September 15, 2026) - Edison issues report on Severfield (LSE: SFR). Severfield is the market leader in the design, fabrication and construction of structural steel in the UK and Europe. Its FY26 results in June were in line with market expectations and accompanied by a refreshed strategy, which was clearly articulated and supported by new medium-term ambitions, including underlying operating margins of 7-8% and £40-50m of underlying PBT. M
Banking / Financial Services, Computer Hardware, Computer Software, Health
2026-09-15 3:38 AM EDT | Edison Group